|Articles|November 1, 2019
- Pharmaceutical Executive-11-01-2019
- Volume 39
- Issue 11
Pharmaceutical Executive, November 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Pharm Exec’s 2020 Pipeline Reportover 6 years ago
R. Jude Samulski: Gene Therapy’s Guiding Forceover 6 years ago
The Pace of Massive Innovationover 6 years ago
The Quest to Measure Drug Effectivenessover 6 years ago
Biosensors in Pharma: A Dose of Optimismover 6 years ago
Closing the Science and Manufacturing Divideover 6 years ago
Country Report: SwedenAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5